Using bioinformatics and genomics to treat AML
Using bioinformatics and genomics to treat AML
Blinatumomab for relapsed/refractory Burkitt's lymphoma
MOR208 plus lenalidomide in r-r diffuse large B-cell lymphoma
Chemoimmunotherapy or BTK inhibition for patients with CLL
CLL12 trial: Ibrutinib in previously untreated, asymptomatic early-stage CLL
CLL14: A chemotherapy-free regimen of venetoclax plus obinutuzumab for CLL
Cancer care in Latin America
Implementing better cancer diagnosis in low and middle income countries
Project Pink Blue: Fighting cancer through increasing awareness, screening, advocacy and patient navigation
Challenges in global cancer control
Novel methods of drug testing and biopsy in India
Inhibition of NADK strongly inhibits T-ALL cells from growing